Changes in expression of the chloride homeostasis-regulating genes, KCC2 and NKCC1, in the blood of cirrhotic patients with hepatic encephalopathy

Li,Jun-Jie; Ji,Ru; Shi,Yong-Quan; Wang,Ya-Yun; Yang,Yan-Ling; Dou,Ke-Feng

doi:10.3892/etm.2012.721

Changes in expression of the chloride homeostasis-regulating genes, KCC2 and NKCC1, in the blood of cirrhotic patients with hepatic encephalopathy

Authors:
- Jun-Jie Li
- Ru Ji
- Yong-Quan Shi
- Ya-Yun Wang
- Yan-Ling Yang
- Ke-Feng Dou
View Affiliations

Affiliations: Department of Anatomy and K.K. Leung Brain Research Centre, Fourth Military Medical University, Xi'an 710032, P.R. China, Department of Digestion, Xi-Jing Hospital, Fourth Military Medical University, Xi'an 710032, P.R. China, Department of Hepatobiliary Surgery, Xi-Jing Hospital, Fourth Military Medical University, Xi'an 710032, P.R. China
Published online on: September 24, 2012 https://doi.org/10.3892/etm.2012.721
Pages: 1075-1080

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatic encephalopathy (HE), a neuropsychiatric abnormality that commonly accompanies cirrhosis of the liver, is often difficult to treat and manage. Changes in chloride homeostasis are involved in the generation of a number of brain disorders. In this study, we considered whether chloride homeostasis is associated with HE. The mRNA levels of the Cl- extrusion system (KCC2) and the Cl- intrusion system (NKCC1) were detected by real-time RT-PCR in the plasma of 29 cirrhotic patients with HE of grade I-II, 36 cirrhotic patients with HE of grade III-IV, 20 cirrhotic patients without HE and 15 healthy controls. The mRNA levels of KCC2 in cirrhotic patients with mild and severe HE were significantly lower compared to those in cirrhotic patients without HE or in the healthy controls. However, NKCC1 mRNA levels did not differ between the different groups. In addition, for cirrhotic patients with HE, there were significant negative correlations between KCC2 levels and the levels of blood ammonia and hepatic function scores (Child‑Pugh and model for end-stage liver disease scores); there was also a significant positive correlation between KCC2 levels and neurological status (Glasgow scores). In conclusion, our study indicates that an imbalance of KCC2 and NKCC1 may be a novel biomarker for detecting HE and for monitoring disease development.

View Figures

View References

1	Jones EA and Mullen KD: Theories of the pathogenesis of hepatic encephalopathy. Clin Liver Dis. 16:7–26. 2012. View Article : Google Scholar : PubMed/NCBI
2	Leke R, Bak LK, Iversen P, Sørensen M, Keiding S, Vilstrup H, Ott P, Portela LV, Schousboe A and Waagepetersen HS: Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy. J Neurochem. 117:824–832. 2011. View Article : Google Scholar : PubMed/NCBI
3	Bismuth M, Funakoshi N, Cadranel JF and Blanc P: Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol. 23:8–22. 2011. View Article : Google Scholar
4	Chamma I, Chevy Q, Poncer JC and Lévi S: Role of the neuronal K-Cl co-transporter KCC2 in inhibitory and excitatory neurotransmission. Front Cell Neurosci. 6:52012. View Article : Google Scholar : PubMed/NCBI
5	Friauf E, Rust MB, Schulenborg T and Hirtz JJ: Chloride cotransporters, chloride homeostasis, and synaptic inhibition in the developing auditory system. Hear Res. 279:96–110. 2011. View Article : Google Scholar : PubMed/NCBI
6	Jayakumar AR and Norenberg MD: The Na-K-Cl co-transporter in astrocyte swelling. Metab Brain Dis. 25:31–38. 2010. View Article : Google Scholar : PubMed/NCBI
7	Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M and Gatta A: Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis. J Hepatol. 28:115–121. 1998. View Article : Google Scholar : PubMed/NCBI
8	Myers RP, Shaheen AA, Aspinall AI, Quinn RR and Burak KW: Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 54:462–470. 2011. View Article : Google Scholar : PubMed/NCBI
9	Vendittelli F, Santonocito C, Paradisi A, Romitelli F, Concolino P, Silveri SL, Sisto T, Capizzi R, Catricalà C, Mulè A, Di Carlo A, Zuppi C and Capoluongo E: A new standardized absolute quantitative RT-PCR method for detection of tyrosinase mRNAs in melanoma patients: technical and operative instructions. Clin Chim Acta. 409:100–105. 2009. View Article : Google Scholar
10	Biolo G, Amoroso A, Savoldi S, Bosutti A, Martone M, Pirulli D, Bianco F, Ulivi S, Bertok S, Artero M, Barazzoni R, Zanetti M, Grassi G, Guarnieri G and Panzetta G: Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. Nephrol Dial Transplant. 21:1317–1322. 2006.
11	Bustin SA, Benes V, Nolan T and Pfaffl MW: Quantitative real-time RT-PCR: a perspective. J Mol Endocrinol. 34:597–601. 2005. View Article : Google Scholar : PubMed/NCBI
12	Aguilar MA, Miñarro J and Felipo V: Chronic moderate hyper-ammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp Neurol. 161:704–713. 2000. View Article : Google Scholar
13	Schafer DF and Jones EA: Hepatic encephalopathy and the gammaaminobutyric-acid neurotransmitter system. Lancet. 1:18–20. 1982. View Article : Google Scholar : PubMed/NCBI
14	Roy S, Pomier-Layrargues G, Butterworth RF and Huet PM: Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology. 8:845–849. 1988. View Article : Google Scholar : PubMed/NCBI
15	Lavoie J, Giguère J-F, Pomier-Layrargues G and Butterworth RF: Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem. 49:692–697. 1987. View Article : Google Scholar : PubMed/NCBI
16	Schafer DF, Fowler JM, Munson PJ, Thakur AK, Waggoner JG and Jones EA: Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J Lab Clin Med. 102:870–880. 1983.PubMed/NCBI
17	Dodd PR, Thomas GJ, Harper CG and Kril JJ: Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver. J Neurochem. 59:1506–1515. 1992. View Article : Google Scholar : PubMed/NCBI
18	Song G, Dhodda VK, Blei AT, Dempsey RJ and Rao VL: GeneChip analysis shows altered mRNA expression of transcripts of neurotransmitter and signal transduction pathways in the cerebral cortex of portacaval shunted rats. J Neurosci Res. 68:1072–1086. 2002. View Article : Google Scholar : PubMed/NCBI
19	Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, Kaiser HJ, Coenen HH, Haussinger D, Zilles K and Bauer A: Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. Eur J Nucl Med Mol Imaging. 35:589–597. 2008. View Article : Google Scholar : PubMed/NCBI
20	Iversen P, Hansen DA, Bender D, Rodell A, Munk OL, Cumming P and Keiding S: Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy. Eur J Nucl Med Mol Imaging. 33:810–816. 2006. View Article : Google Scholar : PubMed/NCBI
21	Cauli O, Mansouri MT, Agusti A and Felipo V: Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology. 136:1359–1367. 2009. View Article : Google Scholar : PubMed/NCBI
22	Obara-Michlewska M, Pannicke T, Karl A, Bringmann A, Reichenbach A, Szeliga M, Hilgier W, Wrzosek A, Szewczyk A and Albrecht J: Down-regulation of Kir 4.1 in the cerebral cortex of rats with liver failure and in cultured astrocytes treated with glutamine: implications for astrocytic dysfunction in hepatic encephalopathy. J Neurosci Res. 89:2018–2027. 2011. View Article : Google Scholar
23	Conti L, Palma E, Roseti C, Lauro C, Cipriani R, de Groot M, Aronica E and Limatola C: Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Epilepsia. 52:1635–1644. 2011. View Article : Google Scholar : PubMed/NCBI
24	Hasbargen T, Ahmed MM, Miranpuri G, Li L, Kahle KT, Resnick D and Sun D: Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury. Ann N Y Acad Sci. 1198:168–172. 2010. View Article : Google Scholar : PubMed/NCBI
25	Fuchs A, Ringer C, Bilkei-Gorzo A, Weihe E, Roeper J and Schütz B: Downregulation of the potassium chloride cotransporter KCC2 in vulnerable motoneurons in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Metab Brain Dis. 25:31–38. 2010.PubMed/NCBI